
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>The list contains several genes associated with mitochondrial function and oxidative phosphorylation, which are crucial for energy production in cells. These include:<br>- **ATP5L, ATP5J2, ATP5E, ATP5C1, ATP5J, ATP5G3, ATP5I, ATP5O, ATP5G2, ATP5A1, ATP5F1, ATP5H, ATP5G1, ATP5B**: These genes encode subunits of ATP synthase, a key enzyme in the mitochondrial electron transport chain responsible for ATP production.<br>- **USMG5, APOA1BP, ATPIF1**: These are involved in mitochondrial function and regulation of ATP synthase activity.<br>- **GNB2L1 (RACK1)**: Involved in various signaling pathways and may play a role in cellular stress responses.<br>- **SELM, SEPW1, SELK, SELT, SEP15**: These are selenoproteins involved in antioxidant defense and redox homeostasis.<br><br>### Step 2: List the Key Cell Type Markers<br>- **HBA2**: Hemoglobin subunit alpha, typically associated with erythroid lineage cells.<br>- **S100A1**: A member of the S100 protein family, often associated with muscle cells, including cardiac and skeletal muscle, and sometimes with certain cancer cells.<br>- **NGFRAP1**: Involved in apoptosis and may be expressed in various cell types, including neurons and some cancer cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, we can cross-reference these markers:<br>- The high expression of ATP synthase subunits suggests a cell type with high metabolic activity, common in cancer cells.<br>- **HBA2** expression is unusual in breast tissue but may indicate erythroid lineage contamination or a specific cancer cell phenotype.<br>- **S100A1** expression could suggest a myoepithelial or muscle-like phenotype, which can be present in certain breast cancer subtypes.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Given the high expression of mitochondrial and oxidative phosphorylation-related genes, the general cell type is likely a cancer cell with high metabolic demands. The presence of **HBA2** and **S100A1** suggests a specialized or aberrant phenotype within the cancer context.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Cancer Cells with Erythroid-like Features**: The presence of **HBA2** suggests a possible erythroid-like phenotype, which can occur in some cancer cells due to aberrant gene expression.<br>2. **Myoepithelial-like Cancer Cells**: The expression of **S100A1** could indicate a myoepithelial-like phenotype, which is sometimes observed in breast cancer.<br>3. **High Metabolic Activity Cancer Cells**: The overall expression profile suggests a highly metabolically active cancer cell, possibly a subtype with increased oxidative phosphorylation.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The cell cluster is most likely composed of cancer cells with high metabolic activity, as indicated by the expression of numerous ATP synthase subunits. The presence of **HBA2** and **S100A1** suggests potential erythroid-like and myoepithelial-like features, respectively. The most probable subtype is a cancer cell with erythroid-like features, given the unusual expression of **HBA2** in breast tissue.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The markers used in the annotation, such as ATP5L, ATP5J2, ATP5E, ATP5C1, ATP5J, ATP5G3, ATP5I, ATP5O, ATP5G2, ATP5A1, ATP5F1, ATP5H, ATP5G1, ATP5B, USMG5, APOA1BP, ATPIF1, GNB2L1, SELM, SEPW1, SELK, SELT, SEP15, HBA2, S100A1, and NGFRAP1, are all present in the provided marker list.<br>   - The markers related to mitochondrial function and oxidative phosphorylation (e.g., ATP synthase subunits) support the identification of a cell type with high metabolic activity, which is typical for cancer cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying potential erythroid-like and myoepithelial-like features within the cancer cell population. This is supported by the presence of markers such as HBA2 and S100A1, which are unusual for breast tissue but can indicate specific cancer phenotypes or contamination.<br>   - The annotation appropriately flags these features for further investigation, acknowledging the complexity of cancer cell phenotypes.<br><br>Overall, the annotation is well-supported by the marker list and provides a plausible explanation for the observed gene expression patterns in the context of breast cancer tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Cancer Cells with High Metabolic Activity</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Cancer Cells with Erythroid-like Features</li><li>Myoepithelial-like Cancer Cells</li><li>High Metabolic Activity Cancer Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough analysis of the single-cell data derived from human breast cancer tissue. The strengths of the annotation include:<br><br>1. **Correctness of Annotations**: The annotation correctly identifies the high metabolic activity of the cancer cells, supported by the presence of numerous ATP synthase subunits. This is a scientifically accurate interpretation given the context of cancer cells, which often exhibit increased oxidative phosphorylation.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis considers a wide range of markers, including those related to mitochondrial function, antioxidant defense, and specific cell type markers like HBA2 and S100A1. This balanced approach ensures that the annotation does not overly focus on a single marker but rather integrates multiple lines of evidence.<br><br>3. **Comprehensive View of Cell Types**: The annotation provides a comprehensive view by suggesting potential subtypes such as cancer cells with erythroid-like features and myoepithelial-like cancer cells. This reflects an understanding of the complexity and heterogeneity of cancer cell populations.<br><br>4. **Consideration of Marker Rank**: The annotation appropriately considers the rank and importance of markers, particularly the emphasis on ATP synthase subunits, which appear frequently and are crucial for identifying high metabolic activity.<br><br>However, there are some areas for improvement:<br><br>1. **Potential Overemphasis on Unusual Markers**: While the presence of HBA2 and S100A1 is noted, the annotation could further explore alternative explanations for their expression, such as technical artifacts or contamination, rather than immediately attributing them to specific cancer phenotypes.<br><br>2. **Lack of Discussion on Marker Variability**: The annotation could benefit from a discussion on the variability of marker expression within the dataset, which might provide additional insights into the heterogeneity of the cell populations.<br><br>Overall, the annotation is scientifically sound and provides a well-rounded interpretation of the data, capturing the general picture of the cell populations present in the breast cancer tissue.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    